Cara Therapeutics
CARA
#10730
Rank
S$10.49 M
Marketcap
S$6.88
Share price
-2.56%
Change (1 day)
20.02%
Change (1 year)

Earnings for Cara Therapeutics (CARA)

Earnings in 2024 (TTM): -S$84.16 Million

According to Cara Therapeutics 's latest financial reports the company's current earnings are S$7.13 Million. , an increase over its 2023 earnings that were of -S$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cara Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -S$81.23 Million-45.49%
2023 -S$0.15 Billion31.6%
2022 -S$0.12 Billion-1.74%
2021 -S$0.12 Billion-1754.28%
2020 S$6.96 M-104.82%
2019 -S$0.15 Billion44.32%
2018 -S$0.11 Billion30.09%
2017 -S$76.95 Million1.86%
2016 -S$75.55 Million131.86%
2015 -S$32.59 Million39.38%
2014 -S$23.38 Million9120.41%
2013 -S$0.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.60 B-41,473.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.69 B-16,966.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-S$40.18 Million-50.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
S$4.86 M-105.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-S$0.11 Billion 26.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-S$0.36 Billion 332.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-S$13.31 Million-83.62%๐Ÿ‡บ๐Ÿ‡ธ USA